Blocking of thromboxane synthase suppresses NNK-induced lung tumorigenesis.
NNK enhances lung cancer stem cells via stimulating thromboxane synthase to activate Akt/GSK3β/β-catenin/Nanog pathway.
Targeting thromboxane synthase appears to be a promising therapeutic option for smoking-related lung cancer.